Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

CYPHCYPH

Showing 0 of 16 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in LEAP THERAPEUTICS INC

As of its Q1 2023 13F, Baker Bros. Advisors held 7,425,570 shares of CYPH (Leap Therapeutics), worth $2.5M. Baker Bros. Advisors' 13F filings listed CYPH from Q3 2019 to Q1 2023, 15 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used